If you need more lookups,
subscriptions start at $34 USD/month.
Charles Liu Location
Chicago, IL, US
Charles Liu Work
Vice President, Neuroscience and Study Start Up, Clinical Study Leadership @ (January 2025 - Present)
Global Head of Study Start Up @ (February 2024 - January 2025)
Head of Business Insights and Study Feasibility, Clinical Study Leadership @ (March 2022 - February 2024)
Senior Director, Innovation @ (April 2021 - March 2022)
Director, Innovation @ (February 2020 - April 2021)
Engagement Manager @ (February 2019 - February 2020)
Associate @ (July 2016 - February 2019)
Summer Associate @ (June 2015 - August 2015)
Business Intelligence (internal consultant) @ (July 2013 - June 2014)
Associate Scientist @ (August 2010 - June 2013)
Research Associate @ (September 2009 - August 2010)
Charles Liu Education
University of Virginia Darden School of Business
Master of Business Administration (MBA) (Masters of Business Administration)
The University of Manchester
Masters (Translational Medicine)
University of Toronto
Honors B.Sc (Chemistry, Human Biology)
Charles Liu Skills
Cancer Research
Clinical Trials
Consulting
Translational Medicine
Clinical Research
Data Analysis
Healthcare
Life Sciences
Strategy
Translational Research
Drug Discovery
Oncology
VBA
Cancer
Diagnostics Development
Research
Pharmaceutical Industry
Personalized Medicine
Analysis
Commercialization
Biopharmaceuticals
Charles Liu Summary
Charles Liu, based in Chicago, IL, US, is currently a Vice President, Neuroscience and Study Start Up, Clinical Study Leadership at AbbVie. Charles Liu brings experience from previous roles at AbbVie. Charles Liu holds a Master of Business Administration (MBA) in Masters of Business Administration @ University of Virginia Darden School of Business. With a robust skill set that includes Cancer Research, Clinical Trials, Consulting, Translational Medicine, Clinical Research and more. Charles Liu has 2 emails and 7 mobile phone numbers on RocketReach.
Looking for a different Charles Liu?
Find contact details for 700 million professionals.